 |
|
Treat all patients with rare lung disease to prevent stroke, say doctors
November 05, 2007Treatment should be offered to all people with a particular rare lung condition, regardless of whether or not they show symptoms of it, say researchers and doctors behind a new study published today.
The research, published online in the journal Thorax, suggests that all patients with abnormal blood vessels in their lungs known as pulmonary arteriovenous malformations ('pulmonary AVMs') might benefit from potentially life-saving treatment to block off the malformed blood vessels.
About 4,000 people in the UK are estimated to have pulmonary AVMs. As many as one in three of them will have a stroke or brain abscess by the age of 65, according to the new research.
Until now, treatment has only been available for small numbers of patients in the UK, because its effectiveness at reducing stroke was not proven and it was widely considered that only those already unwell could benefit from it.
The new study is the first to show that treatment lowers the risk of stroke. The authors - researchers and doctors from Imperial College London and Imperial College Healthcare NHS Trust - believe it is important that treatment is offered to all patients and not just to those who are obviously unwell.
The study reveals that seemingly healthy patients, with one or two pulmonary AVMs, have essentially the same risk of stroke as patients who are obviously unwell and have a number of large pulmonary AVMs.
"Our statistical analysis has shown that it doesn't matter how sick someone is - a pulmonary AVM patient who is fit and well has the same stroke risk as someone who is on oxygen," said Dr Claire Shovlin, from the National Heart and Lung Institute at Imperial College and lead author of the study.
Pulmonary AVMs are strongly linked to a genetic condition called Hereditary Haemorrhagic Telgangiectasia (HHT), which affects around 1 in 5,000 people in the UK. Most people with HHT are well and are unaware that they have the condition until it is diagnosed in a family member.
The authors of the new study call for screening for pulmonary AVMs to be given to all those with HHT. They say that doctors must not be complacent about the wellbeing of people with HHT just because they appear to be healthy.
"In other parts of the world, it is recommended that people with HHT should be screened for pulmonary AVMs and offered treatment for them. At the moment, relatively few individuals in the UK receive this sort of management," added Dr Shovlin.
Pulmonary AVMs are a serious risk to patients because the enlarged blood vessels do not do their job of filtering out small clots or infected material circulating in the blood, thus allowing this material to pass into the brain, potentially causing stroke (clots), or brain abscess (infected material).
Pulmonary AVMs can be treated by a procedure known as embolisation, which is performed under local anaesthesia. The new study shows that this procedure is highly effective at preventing stroke in pulmonary AVM patients. All procedures in the study were carried out by Dr James Jackson, an interventional radiologist at Hammersmith Hospital, which is part of Imperial College Healthcare NHS Trust. Dr Jackson is one of the authors of the new research.
For the pulmonary AVM embolisation, the radiologist passes a fine tube through a blood vessel in the top of the leg and then introduces small metallic coils into the malformed blood vessels. The coils block off the blood supply to the malformed blood vessels and force the blood to flow through healthy blood vessels instead, ensuring that the blood is properly filtered.
"We have shown that healthy individuals with pulmonary AVMs may benefit not only from embolisation, but also from other preventative measures, including improving dental hygiene," said Dr Shovlin.
Improved dental hygiene is important as bacteria from the mouth enter the bloodstream and can pass through pulmonary AVMs and enter the brain.
The cohort study analysed the medical histories of 219 pulmonary AVM patients seen by Dr Shovlin at Hammersmith Hospital from 1999 to 2005. Researchers looked at a huge range of data about the extent of their condition and their general level of health, including the size and number of malformed blood vessels in the lungs, oxygen levels, blood pressure and smoking history. They then compared the data for those patients who had suffered stroke or brain abscess and those who had not.
Imperial College London
Until now, treatment has only been available for small numbers of patients in the UK, because its effectiveness at reducing stroke was not proven and it was widely considered that only those already unwell could benefit from it.
The new study is the first to show that treatment lowers the risk of stroke. The authors - researchers and doctors from Imperial College London and Imperial College Healthcare NHS Trust - believe it is important that treatment is offered to all patients and not just to those who are obviously unwell.
The study reveals that seemingly healthy patients, with one or two pulmonary AVMs, have essentially the same risk of stroke as patients who are obviously unwell and have a number of large pulmonary AVMs.
"Our statistical analysis has shown that it doesn't matter how sick someone is - a pulmonary AVM patient who is fit and well has the same stroke risk as someone who is on oxygen," said Dr Claire Shovlin, from the National Heart and Lung Institute at Imperial College and lead author of the study.
Pulmonary AVMs are strongly linked to a genetic condition called Hereditary Haemorrhagic Telgangiectasia (HHT), which affects around 1 in 5,000 people in the UK. Most people with HHT are well and are unaware that they have the condition until it is diagnosed in a family member.
The authors of the new study call for screening for pulmonary AVMs to be given to all those with HHT. They say that doctors must not be complacent about the wellbeing of people with HHT just because they appear to be healthy.
"In other parts of the world, it is recommended that people with HHT should be screened for pulmonary AVMs and offered treatment for them. At the moment, relatively few individuals in the UK receive this sort of management," added Dr Shovlin.
Pulmonary AVMs are a serious risk to patients because the enlarged blood vessels do not do their job of filtering out small clots or infected material circulating in the blood, thus allowing this material to pass into the brain, potentially causing stroke (clots), or brain abscess (infected material).
Pulmonary AVMs can be treated by a procedure known as embolisation, which is performed under local anaesthesia. The new study shows that this procedure is highly effective at preventing stroke in pulmonary AVM patients. All procedures in the study were carried out by Dr James Jackson, an interventional radiologist at Hammersmith Hospital, which is part of Imperial College Healthcare NHS Trust. Dr Jackson is one of the authors of the new research.
For the pulmonary AVM embolisation, the radiologist passes a fine tube through a blood vessel in the top of the leg and then introduces small metallic coils into the malformed blood vessels. The coils block off the blood supply to the malformed blood vessels and force the blood to flow through healthy blood vessels instead, ensuring that the blood is properly filtered.
"We have shown that healthy individuals with pulmonary AVMs may benefit not only from embolisation, but also from other preventative measures, including improving dental hygiene," said Dr Shovlin.
Improved dental hygiene is important as bacteria from the mouth enter the bloodstream and can pass through pulmonary AVMs and enter the brain.
The cohort study analysed the medical histories of 219 pulmonary AVM patients seen by Dr Shovlin at Hammersmith Hospital from 1999 to 2005. Researchers looked at a huge range of data about the extent of their condition and their general level of health, including the size and number of malformed blood vessels in the lungs, oxygen levels, blood pressure and smoking history. They then compared the data for those patients who had suffered stroke or brain abscess and those who had not.
Imperial College London
Lung Disease News and Current Lung Disease Events RSSResearch examines variations of rare lung disease
Lymphangioleiomyomatosis, or LAM, is a rare but serious lung disease that may cause severe respiratory symptoms in patients. The often-fatal disease has no cure.
Infection Blocks Lung's Protective Response Against Tobacco Smoke
An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health.
Low level cadmium exposure linked to lung disease
New research suggests that cadmium is one of the critical ingredients causing emphysema, and even low-level exposure attained through second-hand smoke and other means may also increase the chance of developing lung disease.
Note to people with scarred and stiffened lungs: Monitor your sleep before severe fatigue sets in
Family, friends and neighbors remember Lisa Sandler Spaeth as an active mother of two in Potomac, Md., with a lot on the go, juggling her son's baseball games and her daughter's horseback-riding lessons with numerous committee obligations, organizing women's activities at her local synagogue.
Beijing pollution may trigger heart attacks, strokes
Olympic athletes aren't the only ones who need to be concerned about the heavily polluted air in Beijing. The dirty air may trigger serious cardiovascular problems for some spectators.
Genetic mutation associated with increased risk of lung cancer
Carriers of a common genetic disorder previously linked to lung disease may have a 70-percent to 100-percent increased risk of lung cancer, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Researchers explore the emerging role of infection in Alzheimer's disease
A number of chronic diseases are in fact caused by one or more infectious agents. For example, stomach ulcers are caused by Helicobacter pylori, chronic lung disease in newborns and chronic asthma in adults are both caused by Mycoplasmas and Chlamydia pneumonia, while some other pathogens have been associated with atherosclerosis.
Tuberculosis not the only risk from new immunological drugs
A new survey cautions physicians that drugs commonly prescribed for patients suffering from immunological disorders such as rheumatoid arthritis and inflammatory bowel disease may carry risks of serious infections other than the known risk of tuberculosis.
COPD patients benefit more from pulmonary rehab in earlier stages
Patients with chronic obstructive pulmonary disease (COPD) who are in their final years of survival do not get the same benefits from pulmonary rehabilitation (PR) as patients who have more years left to live-regardless of their age, complicating illnesses or lung function.
People with obstructive sleep apnea at risk for cardiac stress on airline flights
People with severe obstructive sleep apnea (OSA) on commercial airline flights may have a greater risk of adverse events from cardiac stress than healthy people.
More Lung Disease News Articles
 | Pulmonary Pathophysiology: The Essentials (Pulmonary Pathophysiology) by John B West A companion monograph to West's Respiratory Physiology, which examines normal respiratory function, Pulmonary Pathophysiology focuses on the function of the diseased lung. The text offers a clear, concise overview of the most essential information regarding disease states of the lung, emphasizing structure and function. A question and answer section is included. This Seventh Edition offers more... |
 | Natural Therapies for Emphysema and COPD: Relief and Healing for Chronic Pulmonary Disorders by Robert J. Green Jr. The first book to address emphysema and chronic obstructive pulmonary disease (COPD) from a nutritional and alternative medicine approach • Explains the benefits of detoxification, dietary changes, and food combining • Details 45 suggested herbs and 26 nutritional supplements as well as information on how to stop smoking Approximately 35 million people in the United States have been... |
 | Principles of Pulmonary Medicine (PRINCIPLES OF PULMONARY MEDICINE (WEINBERGER)) by Steven E. Weinberger, Barbara A. Cockrill, Jess Mandel Concise and easy to read, this completely updated new edition correlates basic pathophysiologic principles with the radiologic, pathologic, and clinical aspects of disease to provide an integrated, user-friendly approach to the study of pulmonary medicine. In addition to detailed text, case-based questions cover topics including interpretation of pulmonary function tests, physiologic data, and... |
 | Cardiopulmonary Physical Therapy: A Clinical Manual by Joanne Watchie Summary of reference material related to the physical therapy treatment of patients with cardiac or pulmonary dysfunctions. It includes a variety of information, including normal anatomy and physiology, pathology and pathophysiology of commonly encountered cardiac and pulmonary disorders, laboratory values, diagnostic tests and procedures, surgical interventions, pharmacology, pediatrics, and... |
 | Pulmonary Pathology: A Volume in Foundations in Diagnostic Pathology Series (Foundations in Diagnostic Pathology) by Dani S. Zander, Carol F. Farver This volume in the Foundations in Diagnostic Pathology Series packs today's most essential pulmonary pathology into a compact, high-yield format! It covers both common and rare neoplastic and non-neoplastic diseases of the lung and pleura and focuses primarily on diagnosis with correlations to clinical and radiographic characteristics. Its pragmatic, well-organized approach, abundant full-color... |
 | Fishman's Pulmonary Diseases and Disorders by Alfred P. Fishman, Jack A. Elias, Jay A. Fishman, Michael A. Grippi, Robert M. Senior, Allan Pack A complete guide to the entire field of respiratory medicine-with all-new content and a streamlined new design First published in 1980, Fishman's Pulmonary Diseases & Disorders is the classic reference through which pulmonary physicians have gained a commanding look at the diagnosis and treatment of pulmonary diseases and disorders. Edited by the world's foremost authorities, Fishman's... |
 | Lung Cancer: Myths, Facts, Choices--and Hope by Claudia I. Henschke, Peggy McCarthy, Sarah Wernick Winner of the 2003 American Society of Journalists and Authors' June Roth Memorial Award for Health and Medical Books. An authoritative book with new lifesaving strategies for those at risk and those already diagnosed. Lung cancer kills more women than breast cancer, more men than prostate cancer—because it's usually found too late. Claudia Henschke's groundbreaking research on early... |
 | Breathe Out: Living Life to the Fullest, with Emphysema, COPD, or Smoker's Lung by Mary Callahan RN BREATHE OUT THROUGH PURSED LIPS! Those words are golden for persons with chronic lung disease. Once mastered, the technique can help with everything from going up stairs to picking up a grandchild, all without shortness of breath. That advice and so many more practical tips for getting through the day and getting through life are contained in the pages of this book. Understanding how... |
| Rapid Interpretation of Heart and Lung Sounds: A Guide to Cardiac and Respiratory Auscultation in Dogs and Cats by Francis Smith, Bruce Keene, Larry Tilley This complete resource gives you everything you need to perform accurate auscultation of the heart and lungs in dogs and cats. Use the helpful instructions, ECGs, and phonocardiograms in the companion book as a guide while the clear, easy-to-follow audio CD explains how to identify, interpret, and differentiate heart and lung sounds, including murmurs and arrythmias. Includes self-evaluation... | |
 | 100 Questions & Answers About Lung Cancer (100 Questions & Answers about . . .) by Karen Parles, Joan H. Schiller This book deals with lung cancer from a doctor's perspective and a patient's... |
| © 2008 BrightSurf.com |